[Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].

CONCLUSION: Most clinical studies dealt with an anti-inflammatory or antiproliferative approach. So far, no pharmacological substance has been established for the treatment of PVR but there are promising approaches for prophylaxis. PMID: 32666172 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32666172?dopt=Abstract

Source: Der Ophthalmologe - July 13, 2020 Category: Opthalmology Authors: Schaub F, Abdullatif AM, Fauser S Tags: Ophthalmologe Source Type: research